 Automated planning, AP, can be used to create patient-specific treatment plans for prostate cancer patients. To machine learning, ML approaches have been developed to predict patient-specific planning goals and generate patient-specific AP protocols. These protocols are found to be highly congruent with the gold standard Pareto Navigated Reference Plans, MCOGs. This article was authored by Iona Foster, Emiliano Spezi, and Phillip Wheeler.